DIAGNOSIS AND MANAGEMENT OF ACUTE MYELOID LEUKAEMIA IN PREGNANCY
DIAGNOSIS AND MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM DIFFUSE LARGE B‐CELL LYMPHOMA (PCNSL)
DIAGNOSIS AND MANAGEMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE
DIAGNOSIS, INVESTIGATION AND MANAGEMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA
DIAGNOSIS AND MANAGEMENT OF POLYCYTHAEMIA VERA
MANAGEMENT OF CLASSICAL HODGKIN LYMPHOMA
MANAGEMENT OF DIFFUSE LARGE B-CELL LYMPHOMA
DIAGNOSIS AND MANAGEMENT OF HAIRY CELL LEUKAEMIA AND HAIRY CELL LEUKAEMIA VARIANT
MANAGEMENT AND ADMISSION TO INTENSIVE CARE OF CRITICALLY ILL ADULT PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN THE UK
DIAGNOSIS AND MANAGEMENT OF POST- TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD)
INVESTIGATION AND MANAGEMENT OF TRANSIENT LEUKAEMIA OF DOWN SYNDROME (TL-DS)
DIAGNOSIS AND MANAGEMENT OF COMMON RESPIRATORY VIRAL INFECTIONS IN PATIENTS UNDERGOING TREATMENT FOR HAEMATOLOGICAL MALIGNANCIES OR STEM CELL TRANSPLANTATION
CURRENT MANAGEMENT OF NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
CHRONIC LYMPHOCYTIC LEUKAEMIA: ESMO & BSH CLINICAL PRACTICE GUIDELINES
USE OF IMAGING IN THE MANAGEMENT OF PATIENTS WITH MYELOMA
USE OF JAK INHIBITORS IN THE MANAGEMENT OF MYELOFIBROSIS
SCREENING AND MANAGEMENT OF LATE AND LONG-TERM CONSEQUENCES OF MYELOMA AND ITS TREATMENT
MANAGEMENT OF TUMOUR LYSIS SYNDROME IN ADULTS AND CHILDREN WITH HAEMATOLOGICAL MALIGNANCIES
DIAGNOSIS AND MANAGEMENT OF VENO-OCCLUSIVE DISEASE (SINUSOIDAL OBSTRUCTION SYNDROME) FOLLOWING HAEMATOPOIETIC STEM CELL TRANSPLANTATION
MANAGEMENT OF CYTOMEGALOVIRUS (CMV) INFECTION IN HAEMOPOIETIC STEM CELL TRANSPLANTATION
INVESTIGATION AND MANAGEMENT OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA
GUIDELINES ON THE INVESTIGATION AND MANAGEMENT OF FOLLICULAR LYMPHOMA
MYELODYSPLASTIC SYNDROMES: ESMO CLINICAL PRACTICE GUIDELINES
MULTIPLE MYELOMA: ESMO CLINICAL PRACTICE GUIDELINES
THE MANAGEMENT OF PRIMARY MEDIASTINAL B‐CELL LYMPHOMA: A BRITISH SOCIETY FOR HAEMATOLOGY GOOD PRACTICE PAPER
EUROPEAN LEUKEMIANET 2020 RECOMMENDATIONS FOR TREATING CHRONIC MYELOID LEUKEMIA
DIAGNOSIS AND MANAGEMENT OF ACQUIRED COAGULATION INHIBITORS
ASPECTS OF CANCER-RELATED VENOUS THROMBOSIS
LABORATORY INVESTIGATION OF HERITABLE DISORDERS OF PLATELET FUNCTION
DIAGNOSIS AND TREATMENT OF FACTOR VIII AND IX INHIBITORS IN CONGENITAL HAEMOPHILIA
ASSESSMENT OF BLEEDING RISK PRIOR TO SURGERY OR INVASIVE PROCEDURES
MANAGEMENT OF HAEMOPHILIA IN THE FETUS AND NEONATE
HEPARIN INDUCED THROMBOCYTOPENIA
INVESTIGATION AND MANAGEMENT OF VENOUS THROMBOSIS AT UNUSUAL SITES
DIAGNOSIS AND MANAGEMENT OF VON WILLEBRAND DISEASE
USE OF VENA CAVA FILTERS
MANAGEMENT OF THROMBOTIC AND HAEMOSTATIC ISSUES IN PAEDIATRIC MALIGNANCY
DIAGNOSIS AND MANAGEMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND OTHER THROMBOTIC MICROANGIOPATHIES
PERI-OPERATIVE MANAGEMENT OF ANTICOAGULATION AND ANTIPLATELET THERAPY
CLINICAL GUIDELINES FOR TESTING FOR HERITABLE THROMBOPHILIA
MANAGEMENT OF INHERITED BLEEDING DISORDERS IN PREGNANCY
UKHCDO PROTOCOL FOR FIRST LINE IMMUNE TOLERANCE INDUCTION FOR CHILDREN WITH SEVERE HAEMOPHILIA A: A PROTOCOL FROM THE UKHCDO INHIBITOR AND PAEDIATRIC WORKING PARTIES
DIAGNOSIS AND MANAGEMENT OF MATERNAL THROMBOCYTOPENIA IN PREGNANCY
PATIENT SELF-TESTING AND SELF-MANAGEMENT OF ORAL ANTICOAGULATION WITH VITAMIN K ANTAGONISTS
EMICIZUMAB
GUIDELINES ON THE USE OF PROPHYLACTIC FACTOR REPLACEMENT FOR CHILDREN AND ADULTS WITH HAEMOPHILIA A AND B
INVESTIGATION AND MANAGEMENT OF ACUTE TRANSFUSION REACTIONS
USE OF IRRADIATED BLOOD COMPONENTS
HAEMATOLOGICAL MANAGEMENT OF MAJOR HAEMORRHAGE
MANAGEMENT OF ANAEMIA AND RED CELL TRANSFUSION IN ADULT CRITICALLY ILL PATIENTS
RED CELL TRANSFUSION IN SICKLE CELL DISEASE (SCD)
IDENTIFICATION AND MANAGEMENT OF PRE-OPERATIVE ANAEMIA
PLATELET TRANSFUSION
POST-TRANSFUSION PURPURA
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
SELECTING APPROPRIATE BLOOD PRODUCTS FOR RECIPIENTS OF ABO / RH MISMATCHED STEM CELL TRANSPLANTS
INVESTIGATION AND CLINICAL MANAGEMENT OF PATIENTS WITH A POSITIVE DAT WITH AND WITHOUT HAEMOLYSIS
PAROXYSMAL COLD HAEMOGLOBINURIA (PCH)
RED CELL UNIT FOR INTRAUTERINE TRANSFUSION AND EXCHANGE TRANSFUSION WITH POSITIVE DIRECT ANTIGLOBULIN TEST
GUIDELINES FOR RED CELL TRANSFUSION IN URGENT SITUATIONS AND WHEN SEROLOGICAL COMPATIBILITY CANNOT BE ASSURED
HIGH TITRE ANTI-A/B TESTING OF DONORS
INVESTIGATION AND CLINICAL MANAGEMENT OF SUSPECTED REACTIONS TO IMMUNOGLOBULIN A (IgA)
PROVISION OF RED CELL TRANSFUSION SUPPORT FOR TRANSFUSION DEPENDENT PATIENTS
DIAGNOSIS AND MANAGEMENT OF T ANTIGEN ACTIVATION
CLINICAL GUIDELINES FOR THE USE OF GRANULOCYTE TRANSFUSIONS
MANAGING PATIENTS ON MONOCLONAL ANTIBODY THERAPIES
TRANSFUSION IN THROMBASTHENIA
GUIDELINES FOR THE MANAGEMENT OF PLATELET TRANSFUSION REFRACTORINESS
TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE
GUIDELINE ON THE INVESTIGATION AND MANAGEMENT OF ACUTE TRANSFUSION REACTIONS
GUIDELINES FOR POLICIES ON ALTERNATIVES TO ALLOGENEIC BLOOD TRANSFUSION. 1. PREDEPOSIT AUTOLOGOUS BLOOD DONATION AND TRANSFUSION
THE USE OF ANTI‐D IMMUNOGLOBULIN FOR THE PREVENTION OF HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
THE ESTIMATION OF FETOMATERNAL HAEMORRHAGE
SPECTRUM OF FRESH FROZEN PLASMA AND CRYOPRECIPITATE PRODUCTS
MANAGEMENT OF ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE
DIAGNOSIS AND MANAGEMENT OF ADULT APLASTIC ANAEMIA
DIAGNOSIS AND INVESTIGATION OF AL AMYLOIDOSIS
DIAGNOSIS AND MANAGEMENT OF PRIMARY AUTOIMMUNE HAEMOLYTIC ANAEMIA
INVESTIGATION AND MANAGEMENT OF EOSINOPHILIA
DIAGNOSIS AND THERAPY OF GENETIC HAEMOCHROMATOSIS (GH)
HOW I MANAGE IMMUNE THROMBOCYTOPENIA
THE DIAGNOSIS AND TREATMENT OF COBALAMIN AND FOLATE DISORDERS
THE PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA RECEIVING STEROIDS: A BRITISH SOCIETY FOR HAEMATOLOGY GOOD PRACTICE PAPER
GAUCHER DISEASE
UK GUIDELINES ON THE MANAGEMENT OF IRON DEFICIENCY IN PREGNANCY